MediWound Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.
The company stated in the following document that they conduct pre-clinical trials of their drugs on animals.
“Since NexoBrid was poorly tolerated by the parent animals, these studies are not considered relevant for human risk assessment.” (Page 27) Read the full document
MediWound Ltd. is a biopharmaceutical company that engages in the development, manufacture, and commercialize novel products to address unmet needs in the fields of severe burn; chronic and other hard-to-heal wounds; and connective tissue disorders. Its medicinal product, NexoBrid, is used to remove eschar in adults patients with deep partial- and full-thickness thermal burns. The company was founded by Lior Rosenberg and Marian Gorecki on January 27, 2000 and is headquartered in Yavne, Israel. [Source: MarketWatch]
Company Website: http://www.mediwound.com